Galectin Therapeutics GALT
NASDAQ GALT
$3.76 -0.12 (-3.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Other Non-Current Assets (2010 - 2026)

Updated

Galectin Therapeutics (GALT) recorded Other Non-Current Assets of $167,000 in Q2 2026, down 4.6% from $175,000 a year earlier but up 145.6% from the prior quarter.

Analysis

Galectin Therapeutics (GALT) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Galectin Therapeutics reported Other Non-Current Assets of $96,000, down 60.5% from FY2024.

  • Annual Other Non-Current Assets has declined for three straight years, with a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Assets came in at $243,000 in FY2024 (-50.4%), $490,000 in FY2023 (-33.2%), $733,000 in FY2022 and $7,000 in FY2021 (-94.8%).
  • Quarterly Other Non-Current Assets has ranged from $7,000 in Q4 2021 to $793,000 in Q3 2022 over the past five years.
  • On a year-over-year basis, Other Non-Current Assets has declined for 12 consecutive quarters, with an average decline of 47.9% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 523.1% in Q1 2023, against a decline of 94.8% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $68,000 (Q1 2026), $96,000 (Q4 2025) and $136,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Galectin Therapeutics 257.29 Mn 257.29 Mn - 167,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 167,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 96,000.00
Sep 30, 2025 136,000.00
Jun 30, 2025 175,000.00
Mar 31, 2025 243,000.00
Dec 31, 2024 243,000.00
Sep 30, 2024 306,000.00
Jun 30, 2024 368,000.00
Mar 31, 2024 430,000.00
Dec 31, 2023 490,000.00
Sep 30, 2023 552,000.00
Jun 30, 2023 613,000.00
Mar 31, 2023 673,000.00
Dec 31, 2022 733,000.00
Sep 30, 2022 793,000.00
Jun 30, 2022 101,000.00
Mar 31, 2022 108,000.00
Dec 31, 2021 7,000.00
Sep 30, 2021 40,000.00
API Access

Galectin Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GALT&period=max&api_key=YOUR_API_KEY